Fig. 2
Two-dimensional (2D) binding mode and residues involved in the recognition of (a) celecoxib, (b) bisabolol, the most potent compounds; (c) metabolite 4, (d) metabolite 5 and (e) metabolite 6 docked and minimized in the COX-2 binding pocket.
Fig. 2 | Scientific Reports
